Literatur
- 1
Zugck C, Remppis A, Katus H A, Rauch B, Haass M.
Ansätze zur Optimierung der Therapie der chronischen Herzinsuffizienz.
Kardiologie up2date.
2006;
2
51-70
- 2
Jünger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M.
Health related quality of life in patients with congestive heart failure: comparison
with other chronic diseases and relation to functional variables.
Heart.
2002;
87
235-241
- 3
Van Melle J P, deJonge P, Spijkerman T A. et al .
Prognostic association of depression following myocardial infarction with mortality
and cardiovascular events: a meta-analysis.
Psychosom Med.
2004;
66
814-822
- 4
Barth J, Schumacher M, Hermann-Lingen C.
Depression as a rsik factor for mortality in patients with coronary artery disease:
a meta-analysis.
Psychosom Med.
2004;
66
802-813
- 5
Rutledge T, Reis V A, Linke S E, Greenberg B H, Mills P J.
Depression in heart failure.
J Am Coll Cardiol.
2006;
48
1527-1537
- 6
O’Connor C M, Joynt K E.
Depression: are we ignoring an important comorbidity in heart failure?.
J Am Coll Cardiol.
2004;
43
1550-1552
- 7
Abramson J, Berger A, Krumholz H M, Vaccarino V.
Depression and risk of heart failure among older persons with isolated systolic hypertension.
Arch Intern Med.
2001;
161
1725-1730
- 8
Musselman D L, Tomer A, Manatunga A K. et al .
Exaggerated platelet reactivity in major depression.
Am J Psychiatry.
1996;
153
1313-1317
- 9
Parissis J T, Fountoulaki K, Paraskevaidis I, Kremastinos D.
Depression in chronic heart failure: novel pathophysiological mechanisms and approaches.
Expert Opin. Investig.
Drugs.
2005;
14
567-577
- 10
Ko D T, Herbert P R, Coffey C S, Sedrakyan A, Curtis J P, Krumholz H M.
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.
JAMA.
2002;
288
351-357
- 11
van Melle J P, Verbeek D E, van den Berg M P, Ormel J, van der Linde M R, deJonge P.
Beta-blockers and depression after myocardial infarction - a multicenter prospective
study.
J Am Coll Cardiol.
2006;
48
2209-2214
- 12
Steptoe A, Mohabir A, Mahon N G, McKenna W J.
Health related quality of life and psychological wellbeing in patients with dilated
cardiomyopathy.
Heart.
2000;
83
645-655
- 13
Ruo B, Rumsfeld J S, Hlatky M A, Liu H, Browner W S, Whooley M A.
Depressive symptoms and health-related quality of life: the Heart and Soul Study.
JAMA.
2003;
290
215-221
- 14
Lee J K, Grace K A, Taylor A J.
Effect of pharmacy care program on medication adherence and persistence, blood pressure,
and low-density lipoprotein cholesterol: a randomized controlled trial.
JAMA.
2006;
296
2563-2571
- 15
DiMatteo M R, Lepper H S, Croghan T W.
Depression is a risk factor for non-compliance with medical treatment: meta-analysis
of the effects of anxiety and depression on patient adherence.
Arch Int Med.
2000;
160
2101-2107
- 16
Jiang W, Alexander J, Kuchibhatia M. et al .
Relationship of depression to increased risk of mortality and rehospitalisation in
patients with congestive heart failure.
Arch Intern Med.
2001;
161
1849-1856
- 17
Himelhoch S, Weller W E, Wu A W, Anderson G F, Cooper L A.
Chronic medical illness, depression, and use of acute medical services among Medicare
beneficiaries.
Med Care.
2004;
45
512-521
- 18
Sullivan M D, Levy W C, Crane B A, Russo J E, Spertus J A.
Usefulness of depression to predict time to combined endpoint of transplant or death
for outpatients with advanced heart failure.
Am J Cardiol.
2004;
94
1577-1580
- 19
Jünger J, Schellberg D, Müller-Tasch T. et al .
Depression increasingly predicts mortality in the course of congestive heart failure.
Eur J Heart Fail.
2005;
7
261-267
- 20
Gold P W, Chrousos G P.
The endocrinology of melancholic and atypical depression: relation to neurocircuitory
and somatic consequences.
Proc Assoc Am Physicians.
1999;
111
22-34
- 21
Zipfel S, Schneider A, Wild B. et al .
Effect of depressive symptoms on survival after heart transplantation.
Psychosom Med.
2002;
64
740-747
- 22
Glassman A H, O’Connor C M, Califf R M. et al .
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA.
2002;
288
701-709
- 23
Glassman A H, Roose S P, Bigger Jr J T.
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.
JAMA.
1993;
269
2673-2675
- 24
van den Brink R H, van Melle J P, Honig A, Schene A H, Crijns H J, Lambert F P, Ormel J.
Treatment of depression after myocardial infarction and the effects on cardiac prognosis
and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention
Trial (MIND-IT).
Am Heart J.
2002;
144
219-225
- 25
Berkman L F, Blumenthal J, Burg M. et al .
Effects of treating depression and low perceived social support on clinical events
after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients
(ENRICHD) Randomized Trial.
JAMA.
2003;
289
3106-3116
- 26
Lesperance F, Frasure-Smith N, Koszycki D, Laliberte M-A. et al .
, for the CREAZE Investigators. Effects of citalopram and interpersonal psychotherapy
on depression in patients with coronary artery disease. The Canadian Cardiac Randomized
Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial.
JAMA.
2007;
297
367-379
- 27
Lane D A, Chong A Y, Lip G Y.
Psychological interventions for depression in heart failure.
Cochrane Database Syst Rev.
2005;
(1)
CD003329
- 28
Radewitz A, Miche E, Herrmann G. et al .
Exercise and muscle strength training and their effect on quality of life in patients
with heart failure.
Eur Heart Fail J.
2002;
4
627-634
- 29
MacMahon K M, Lip G Y.
Psychological factors in heart failure: a review of the literature.
Arch Intern Med.
2002;
162
509-516
- 30
Jiang W, Kuchibhatia M, Cuffe M S. et al .
Prognostic value of anxiety and depression in patients with chronic heart failure.
Circulation.
2004;
110
3452-3456
- 31
Sears Jr S F, Conti J B.
Quality of life and psychological functioning of ICD patients.
Heart.
2002;
87
488-493
- 32
Davies S J, Jackson P R, Potokar J, Nutt D J.
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
Br Med J.
2004;
328
939-943
1 Mit Unterstützung durch das Kompetenznetz Herzinsuffizienz, gefördert vom Deutschen
Bundesministerium für Bildung und Forschung (BMBF)
Prof. Dr. Markus Haass
Innere Medizin I
Kardiologie, Angiologie und Internistische Intensivmedizin, Theresienkrankenhaus
Bassermannstr. 1
68165 Mannheim
eMail: m.haass@theresienkrankenhaus.de
